← Leaderboards
Melissa Allard
Albany Molecular Research, Inc.
$16,991,646
Attributed
$16,991,646
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5M · FY2018–24$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$16,991,646 · 3
By mechanism
N01$16,991,646 · 3
Top collaborators
No co-investigators on record.
Most similar at Albany Molecular Research, Inc.
Same institution · by research overlap
- Keith Barnes$45,425,605
- John Reilly$2,579,604
- Greg Martin$1,915,086
- Gregory Martin$806,362
- Matt Surman$1,796,372
Others in their field
Other Emerging Leaders on “Programs”
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$348,328,584
- Lynn Briscoe · Leidos Biomedical Research, Inc.$312,382,073
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
ProgramsChemistryUnited States National Institutes Of HealthSmall MoleculeContractsNovel TherapeuticsContractorPharmaceutical PreparationsFormulationDrug CandidateClinical TrialsInvestigational New Drug ApplicationGrantInvestigational DrugsPreparationRegulationLabelDrug DevelopmentGood Laboratory PracticePharmacologic SubstanceMethod DevelopmentDocumentationAnalytical MethodPreclinical Efficacy
Grant awards (24)
FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS$89,686
N01 · FY2024 · DA · contact PI
MCSP TORFP NO. NIH-NINDS-21-01: FLORIO (ANAGIN) - BASE EC (STROKE)$1,476,441
N01 · FY2023 · DA · contact PI
MCSP TORFP NO. NIH-NINDS-21-01: FLORIO (ANAGIN) - BASE EC (STROKE)$1,311,329
N01 · FY2022 · DA · contact PI
FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS$1,046,113
N01 · FY2022 · DA · contact PI
Task C18: APP Drug Candidate Manufacture Services$218,000
N01 · FY2022 · AI · contact PI
MCNAMARA EXPLORATORY CHEMISTRY$1,434,146
N01 · FY2021 · DA · contact PI
ALBANY MOLECULAR RESEARCH INC - BOZIK BPN 25203$1,230,215
N01 · FY2021 · DA · contact PI
MCSP TORFP NO. NIH-NINDS-21-01: FLORIO (ANAGIN) - BASE EC (STROKE)$632,321
N01 · FY2021 · DA · contact PI
MEDICINAL CHEMISTRY - BASE EXPLORATORY CHEMISTRY (ALZHEIMER'S DISEASE)$607,397
N01 · FY2021 · DA · contact PI
MULCAHY EXPLORATORY CHEMISTRY$515,228
N01 · FY2021 · DA · contact PI
ALBANY MOLECULAR RESEARCH, INC: WAGNER UCSD-0776890 ICH STABILITY STUDY. DMFP.$26,141
N01 · FY2021 · DA · contact PI
MCNAMARA EXPLORATORY CHEMISTRY$1,268,750
N01 · FY2020 · DA · contact PI
ALBANY MOLECULAR RESEARCH INC - BOZIK BPN 25203$1,029,497
N01 · FY2020 · DA · contact PI
MULCAHY EXPLORATORY CHEMISTRY$905,711
N01 · FY2020 · DA · contact PI
ALBANY MOLECULAR RESEARCH INC:1106422 [20-006949]$160,419
N01 · FY2020 · DA · contact PI
Task C03: Non-GMP manufacturing of a compound with activity against gram negative bacteria$860,167
N01 · FY2019 · AI · contact PI
ALBANY MOLECULAR RESEARCH INC - ROSENZWEIG$859,262
N01 · FY2019 · NS · contact PI
Task C02: Non-GMP manufacturing of a compound with activity against gram negative bacteria$852,008
N01 · FY2019 · AI · contact PI
MULCAHY EXPLORATORY CHEMISTRY$688,848
N01 · FY2019 · DA · contact PI
MCNAMARA EXPLORATORY CHEMISTRY$611,466
N01 · FY2019 · DA · contact PI
ALBANY MOLECULAR RESEARCH, INC(AMRI)[19-002417]MCSP TASK ORDER XU PROJECT - EXPLORATORY CHEMISTRY POP: TBD$575,359
N01 · FY2019 · DA · contact PI
ALBANY MOLECULAR RESEARCH INC - BOZIK BPN 25203$529,120
N01 · FY2019 · NS · contact PI
ALBANY MOLECULAR RESEARCH, INC: WAGNER UCSD-0776890 ICH STABILITY STUDY. DMFP.$45,725
N01 · FY2019 · NS · contact PI
Task F01: Non-clinical Services for Development of Interventional Agents for Infectious Diseases$18,297
N01 · FY2018 · AI · contact PI